cdk 1 2 sc 53219 (Santa Cruz Biotechnology)
Santa Cruz Biotechnology is a verified supplier 
93
Structured Review
Santa Cruz Biotechnology
cdk 1 2 sc 53219
Cdk 1 2 Sc 53219, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 87 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk1+cdk2/Cdk1%2FCdk2+Antibody/pm41873693-167-40-43
Average 93 stars, based on 87 article reviews
Cdk 1 2 Sc 53219, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 87 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk1+cdk2/Cdk1%2FCdk2+Antibody/pm41873693-167-40-43
Average 93 stars, based on 87 article reviews
cdk 1 2 sc 53219 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
other:Article Title: Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer. Article Snippet: The specific primary antibodies include against SPHK1 (1:1000, CST, 12071S, Danvers, MA, USA), PBX1 (1:1000, CST, 4342S, Danvers, MA, USA), Phospho-Akt (Ser 473; 1:1000, CST, 4060S, Danvers, MA, USA), Akt (1:1000, CST, 4685S, Danvers, MA, USA), Phospho-p44/42 MAPK (Thr202/Tyr204; 1:1000, CST, 4370S, Danvers, MA, USA), S1PR3 (1:1000, Abcam, ab126622, Cambridge, UK), S1PR1 (1:1000, Abcam, ab23386, Cambridge, UK), Article Title: 20(S)-ginsenoside Rg3 suppresses gastric cancer cell proliferation by inhibiting E2F-DP dimerization. Article Snippet: Background: Gastric cancer (GC) is a common and aggressive malignancy, with treatment options often limited by drug resistance and the adverse effects of targeted therapies and immunotherapy.. Ginsenoside Rg3, a bioactive compound derived from ginseng, has shown promise in inhibiting the growth of various tumor types, including GC.. However, the molecular mechanisms underlying its therapeutic effects against GC remain insufficiently Article Title: Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer Article Snippet: The specific primary antibodies include against SPHK1 (1:1000, CST, 12071S, Danvers, MA, USA), PBX1 (1:1000, CST, 4342S, Danvers, MA, USA), Phospho-Akt (Ser 473; 1:1000, CST, 4060S, Danvers, MA, USA), Akt (1:1000, CST, 4685S, Danvers, MA, USA), Phospho-p44/42 MAPK (Thr202/Tyr204; 1:1000, CST, 4370S, Danvers, MA, USA), S1PR3 (1:1000, Abcam, ab126622, Cambridge, UK), S1PR1 (1:1000, Abcam, ab23386, Cambridge, UK), Western Blot:Article Title: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers Article Snippet: .. Primary antibodies to the following proteins were used for immunoblotting: RNAPII CTD S2 (Bethyl laboratories inc, Montgomery, TX, USA A300-654A), RNAPII CTD S5 (Bethyl A304-408A), RNAPII CTD S7 (Millipore, Charlottesville, VA, USA 04-1570), RNA Pol II (Bethyl A300-653A), cleaved PARP (Cell Signaling Technology [CST], Danvers, MA, USA 9541), phospho-Rb (ser780) (CST 5 9307), Rb (CST 9309), E2F-1 (CST 3742), phospho-cdc2 (Thr161) (CST 9114), Article Title: REST regulates the cell cycle for cardiac development and regeneration Article Snippet: .. Antibodies, including REST (Antibodies-online, ABIN747683, 1:1000), P21 (Abcam, ab109199, 1:500), Cyclin E (Santa Cruz, sc-377100, 1:1000), Cyclin B (Santa Cruz, sc-166210, 1:1000), |